INSM.NASDAQInsmed INC

Form 4: Insmed Inc. Executive Michael Smith Reports Stock and Option Awards

Sentiment:

SEC Form 4 Filing


Chief Legal Officer Michael Alexander Smith reports the acquisition of restricted stock units and stock options in Insmed Inc.

Summary

  • On May 15, 2025, Michael Alexander Smith, Chief Legal Officer of Insmed Inc., reported the acquisition of 5,578 shares of common stock in the form of Restricted Stock Units (RSUs) and 27,100 stock options.
  • The RSUs were granted under the company's Amended and Restated 2019 Incentive Plan and vest 25% on the first day of the first month following the first anniversary of the grant date, with the remaining vesting annually.
  • The stock options, also granted under the 2019 Incentive Plan, vest 25% on the initial vesting date and an additional 12.5% every six months thereafter until fully vested, with an exercise price of $67.22 and expire on 05/15/2035.
  • Following these transactions, Smith directly owns 97,372 shares of Insmed Inc. common stock and 27,100 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of executive compensation. The vesting schedules suggest a long-term commitment, which is mildly positive.

Positives

  • The grant of RSUs and stock options to a key executive like the Chief Legal Officer suggests the company's commitment to aligning management's interests with those of shareholders.
  • The vesting schedules for both RSUs and stock options incentivize long-term performance and retention of the executive.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into the holdings and transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and alignment with shareholder interests.

Stakeholder Impact

  • The grant of equity to executives can align their interests with those of shareholders, potentially leading to better company performance.
  • Employees may view executive compensation packages as a reflection of the company's overall health and commitment to its workforce.

Key Dates

DateDescription
05/15/2025Date of the reported transaction (grant of RSUs and stock options)
05/19/2025Date of signature on the Form 4 filing
05/15/2035Expiration date of the stock options

Keywords

Insmed, Michael Smith, Stock Options, Restricted Stock Units, Beneficial Ownership, Form 4, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.